tetano
Editor, Senior Moderator
Maternal Influenza Vaccination and Effect on Influenza Virus Infection in Young Infants
Angelia A. Eick, PhD; Timothy M. Uyeki, MD, MPH, MPP; Alexander Klimov, PhD; Henrietta Hall, MS; Raymond Reid, MD; Mathuram Santosham, MD; Katherine L. O?Brien, MD, MPH
Arch Pediatr Adolesc Med. Published online October 4, 2010. doi:10.1001/archpediatrics.2010.192
Objective To assess the effect of seasonal influenza vaccination during pregnancy on laboratory-confirmed influenza in infants to 6 months of age.
Design Nonrandomized, prospective, observational cohort study.
Setting Navajo and White Mountain Apache Indian reservations, including 6 hospitals on the Navajo reservation and 1 on the White Mountain Apache reservation.
Participants A total of 1169 mother-infant pairs with mothers who delivered an infant during 1 of 3 influenza seasons.
Main Exposure Maternal seasonal influenza vaccination.
Main Outcome Measures In infants, laboratory-confirmed influenza, influenzalike illness (ILI), ILI hospitalization, and influenza hemagglutinin inhibition antibody titers.
Results A total of 160 mother-infant pairs had serum collected and were included in the analysis. Among infants, 193 (17%) had an ILI hospitalization, 412 (36%) had only an ILI outpatient visit, and 555 (48%) had no ILI episodes. The ILI incidence rate was 7.2 and 6.7 per 1000 person-days for infants born to unvaccinated and vaccinated women, respectively. There was a 41% reduction in the risk of laboratory-confirmed influenza virus infection (relative risk, 0.59; 95% confidence interval, 0.37-0.93) and a 39% reduction in the risk of ILI hospitalization (relative risk, 0.61; 95% confidence interval, 0.45-0.84) for infants born to influenza-vaccinated women compared with infants born to unvaccinated mothers. Infants born to influenza-vaccinated women had significantly higher hemagglutinin inhibition antibody titers at birth and at 2 to 3 months of age than infants of unvaccinated mothers for all 8 influenza virus strains investigated.
Conclusions Maternal influenza vaccination was significantly associated with reduced risk of influenza virus infection and hospitalization for an ILI up to 6 months of age and increased influenza antibody titers in infants through 2 to 3 months of age.
Author Affiliations: Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (Drs Eick, Reid, Santosham, and O?Brien); Influenza Division, National Center for Immunization and Respiratory Viruses, Centers for Disease Control and Prevention, Atlanta, Georgia (Drs Uyeki and Klimov and Ms Hall). Dr Eick is now with the Armed Forces Health Surveillance Center, Silver Spring, Maryland.
http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2010.192
Angelia A. Eick, PhD; Timothy M. Uyeki, MD, MPH, MPP; Alexander Klimov, PhD; Henrietta Hall, MS; Raymond Reid, MD; Mathuram Santosham, MD; Katherine L. O?Brien, MD, MPH
Arch Pediatr Adolesc Med. Published online October 4, 2010. doi:10.1001/archpediatrics.2010.192
Objective To assess the effect of seasonal influenza vaccination during pregnancy on laboratory-confirmed influenza in infants to 6 months of age.
Design Nonrandomized, prospective, observational cohort study.
Setting Navajo and White Mountain Apache Indian reservations, including 6 hospitals on the Navajo reservation and 1 on the White Mountain Apache reservation.
Participants A total of 1169 mother-infant pairs with mothers who delivered an infant during 1 of 3 influenza seasons.
Main Exposure Maternal seasonal influenza vaccination.
Main Outcome Measures In infants, laboratory-confirmed influenza, influenzalike illness (ILI), ILI hospitalization, and influenza hemagglutinin inhibition antibody titers.
Results A total of 160 mother-infant pairs had serum collected and were included in the analysis. Among infants, 193 (17%) had an ILI hospitalization, 412 (36%) had only an ILI outpatient visit, and 555 (48%) had no ILI episodes. The ILI incidence rate was 7.2 and 6.7 per 1000 person-days for infants born to unvaccinated and vaccinated women, respectively. There was a 41% reduction in the risk of laboratory-confirmed influenza virus infection (relative risk, 0.59; 95% confidence interval, 0.37-0.93) and a 39% reduction in the risk of ILI hospitalization (relative risk, 0.61; 95% confidence interval, 0.45-0.84) for infants born to influenza-vaccinated women compared with infants born to unvaccinated mothers. Infants born to influenza-vaccinated women had significantly higher hemagglutinin inhibition antibody titers at birth and at 2 to 3 months of age than infants of unvaccinated mothers for all 8 influenza virus strains investigated.
Conclusions Maternal influenza vaccination was significantly associated with reduced risk of influenza virus infection and hospitalization for an ILI up to 6 months of age and increased influenza antibody titers in infants through 2 to 3 months of age.
Author Affiliations: Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (Drs Eick, Reid, Santosham, and O?Brien); Influenza Division, National Center for Immunization and Respiratory Viruses, Centers for Disease Control and Prevention, Atlanta, Georgia (Drs Uyeki and Klimov and Ms Hall). Dr Eick is now with the Armed Forces Health Surveillance Center, Silver Spring, Maryland.
http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2010.192